Alkermes Plc (NASDAQ:ALKS)

60.57
Delayed Data
As of May 27
 +0.76 / +1.26%
Today’s Change
38.49
Today|||52-Week Range
75.17
+3.43%
Year-to-Date

Today’s Trading

Previous close59.82
Today’s open60.17
Day’s range-- - --
Volume682,521
Average volume (3 months)1,327,494
Market cap$8.9B
Dividend yield--
Data as of 05/27/2015

Growth & Valuation

Earnings growth (last year)-229.95%
Earnings growth (this year)-221.34%
Earnings growth (next 5 years)+54.64%
Revenue growth (last year)+7.20%
P/E ratioNM
Price/Sales13.75
Price/Book6.32

Competitors

 Today’s
change
Today’s
% change
UTHRUnited Therapeutics ...+0.96+0.53%
RDYDr.Reddy's Laborator...+0.79+1.44%
OPKOPKO Health Inc+0.16+0.90%
MDVNMedivation Inc+2.89+2.25%
Data as of 05/27/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$618.8M
Annual profit (last year)-$30.1M
Net profit margin-4.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers